Description

Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

New drugs include:

apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)

Subscriptions are $9.99 for one year. Your subscription will auto-renew annually at the end of each year-long term, unless cancelled. Payment will be charged to your iTunes Account at confirmation of purchase. The subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Your account will be charged $9.99 for renewal within 24-hours prior to the end of the current period. Subscriptions may be managed and auto-renewal may be turned off by going to your Account Settings after purchase. No cancellation of the current subscription is allowed during active subscription period. Any unused portion of a free trial period, if offered, will be forfeited when the user purchases a subscription to that publication. Please see the links to our privacy policy and terms of service below.

Privacy Policy - http://www.jblearning.com/privacy/

Terms of Use - http://www.jblearning.com/use/

Print Book - http://www.jblearning.com/catalog/9781284054613/

Hide.. Show more..

In-Apps

One Year Subscription: $9.99

Screenshots

User Rating

4.31 out of 5

16 ratings in United States

5 star

4 star

3 star

2 star

1 star

Ratings History

Reviews

Look at year of references & last update

References from 2003, 2013, & 2018. Last update 3 years ago. I love the idea of this app & the way it is set up, but come on… Why is there an annual fee for app that isn’t updated?

Quick and easy to use resource

Store Rankings

Ranking History

App Ranking History not available yet

Category Rankings

Chart	Category	Rank
Top Grossing	Greece Medical	30
Top Grossing	South Africa Medical	79

Keywords

Users may also like

Name	Reviews	Recent release
Hematology & Oncology Consult Washington Manual Series	0	4 years ago
Manual of Clinical Oncology with Expert Recommentations	1	7 months ago
ASCO Guidelines	4	7 months ago
Cancer Therapy Advisor	0	2 years ago
Hem/Onc @Point of Care Hematology & Oncology	0	1 month ago
Oncology Board Exam Review Certification Flashcards	0	5 years ago
ChemoPalRx	0	5 years ago
Oncology Nursing Drug Handbook Caring for cancer patients	0	3 years ago
NCCN Patient Guides for Cancer	2	4 years ago
N/A/ N/A/	0	7 years ago